These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Management of Raynaud's phenomenon]. Boccalon H; Monin A; Reggy M Soins Cardiol; 1986 Apr; (38):27-9. PubMed ID: 3637023 [No Abstract] [Full Text] [Related]
25. Ketanserin versus nifedipine in secondary Raynaud's phenomenon. Kirch W; Linder HR; Hutt HJ; Ohnhaus EE; Mahler F Vasa; 1987; 16(1):77-80. PubMed ID: 3554811 [No Abstract] [Full Text] [Related]
26. Treatment of Raynaud's phenomenon. García-Carrasco M; Jiménez-Hernández M; Escárcega RO; Mendoza-Pinto C; Pardo-Santos R; Levy R; Maldonado CG; Chávez GP; Cervera R Autoimmun Rev; 2008 Oct; 8(1):62-8. PubMed ID: 18692160 [TBL] [Abstract][Full Text] [Related]
27. [The therapy of Raynaud's phenomenon]. Di Giacinto G Clin Ter; 1993 Feb; 142(2):161-74. PubMed ID: 8472530 [TBL] [Abstract][Full Text] [Related]
28. Does serotonin receptor blockade have a therapeutic effect in Raynaud's phenomenon? Brouwer RM; Wenting GJ; Visser W; Schalekamp MA Vasa Suppl; 1987; 18():64-7. PubMed ID: 3299817 [No Abstract] [Full Text] [Related]
29. [Treatment of Raynaud's phenomenon with alpha-lytic agents]. Clément DL Rev Med Liege; 1980 Oct; 35(19):650-2. PubMed ID: 6109369 [No Abstract] [Full Text] [Related]
30. New prospects for the treatment of Raynaud's phenomenon using a serotoninergic S2 receptor antagonist (ketanserin) and stable derivatives of prostacyclin. Pola P; Tondi P; Serricchio M; Favuzzi A; Gerardino L Angiology; 1993 Feb; 44(2):123-8. PubMed ID: 8434805 [TBL] [Abstract][Full Text] [Related]
31. Effect of chronic ketanserin treatment on serotonin-induced platelet aggregation in patients with Raynaud's phenomenon. Marasini B; Biondi ML; Mollica R Eur J Clin Pharmacol; 1990; 39(3):289-90. PubMed ID: 2257869 [TBL] [Abstract][Full Text] [Related]
32. [Treatment of Raynaud's syndrome with calcium entry blockers]. Shcherbakov AB; Guseva NG; Mach ES Ter Arkh; 1987; 59(4):89-92. PubMed ID: 3296288 [TBL] [Abstract][Full Text] [Related]
33. [How I treat...Raynaud's phenomenon]. Piérard GE Rev Med Liege; 1998 Mar; 53(3):119-20. PubMed ID: 9594609 [TBL] [Abstract][Full Text] [Related]
34. Hypertensive patients with Raynaud's phenomenon or intermittent claudication and their treatment with ketanserin. van Oene JC Drugs; 1988; 36 Suppl 1():148-51. PubMed ID: 3240729 [No Abstract] [Full Text] [Related]
35. Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis. Thompson AE; Shea B; Welch V; Fenlon D; Pope JE Arthritis Rheum; 2001 Aug; 44(8):1841-7. PubMed ID: 11508437 [TBL] [Abstract][Full Text] [Related]